TABLE 4

Univariate and multivariate logistic models for persistent bacteremiab

FactorUnivariate modelMultivariate model
OR95% CIP valueOR95% CIP value
Cefepime treatment5.250.56–49.00.159.700.87–108.040.07
Piperacillin-tazobactam treatment12.01.14–126.10.0427.061.79–410.080.02
Carbapenem treatment (reference)
Age0.940.89–0.980.010.920.87–0.98<0.01
Neutropeniaa0.840.08–8.400.88
Pitt bacteremia score0.940.56–1.570.80
Leukemia0.920.17–5.110.93
History of HCT0.600.14–2.610.50
Female gender0.350.07–1.830.21
Active chemotherapy0.570.10–3.350.54
ICU residence1.430.57–3.560.45
Intra-abdominal source3.270.75–14.200.11
Combination aminoglycoside0.510.12–2.200.36
  • a Absolute neutrophil count (ANC) < 500 cells/mm3.

  • b OR, odds ratio; CI, confidence interval; HCT, hematopoietic stem cell transplant; ICU, intensive care unit.